News | October 28, 2013

AliveCor Supports UCSF’s Online Health eHeart Study

AliveCor Heart Monitors Provide Mobile Access to Measure Heart Health

ecg software mobile devices alivecor heart monitor university san francisco
October 28, 2013 — Alivecor Inc. announced that the AliveCor Heart Monitor is now being offered to participants in the Health eHeart Study with 2,000 units to be deployed before the end of the year. The University of California, San Francisco’s (UCSF) Health eHeart Study aims to enroll one million participants and monitor heart health for at least 10 years.
 
The goal of the study is to better understand which factors impact heart health long-term and thereby develop better methods to predict, prevent and treat cardiovascular disease.
 
The AliveCor Heart Monitor is the only mobile electrocardiogram (ECG) device that supports both iPhone and Android compatible smartphones. It records, displays, annotates, stores and transfers single-channel ECG rhythms wirelessly using the free AliveECG application. 
 
Overall ease of use and convenience is further expanded with AliveInsights for tracking of heart rate and the Enhanced Filter that improves visual output of the ECG. Over 300,000 ECGs have been recorded to date with the heart monitor. With secure storage in the Cloud, patients can access their data confidentially any time, anywhere and can grant access to their physician.
 
“The goal of Health eHeart Study is to expand on traditional research studies, which have identified common risk factors for heart disease by studying several thousand people with yearly or biannual visits to the clinic for tests and examination, such as an ECG,” said Jeffrey Olgin, M.D., chief of the division of cardiology, UCSF and one of the principal investigators, Health eHeart Study. “The Health eHeart Study expands on these types of studies by being able to track participants anywhere in the world and receive data any time they choose to send their information. The AliveCor Heart Monitor helps us collect ECG data on large numbers of people and at much more frequent intervals simply through their smartphone.”
 
The AliveCor Heart Monitor is available for purchase in the United States to medical professionals and patients with prescriptions.
 
For more information: www.alivecor.com
 

Related Content

FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...
EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019
January 8, 2019 — A Mayo Clinic study finds that applying...
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Overlay Init